NCT02294084View on ClinicalTrials.gov

Sitagliptin and Brown Adipose Tissue

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

October 31, 2016

Study Completion Date

December 31, 2016

Conditions
Neoplasms, Adipose Tissue
Interventions
DRUG

Sitagliptin

Each subject in this arm will receive Sitagliptin (100mg/day) for a duration of 12 weeks.

DRUG

placebo

Each subject will receive a placebo (once a day) for 12 weeks.

Trial Locations (1)

2333 ZA

Leiden University Medical Center, Leiden

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

Ingrid Jazet

OTHER

NCT02294084 - Sitagliptin and Brown Adipose Tissue | Biotech Hunter | Biotech Hunter